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ABSTRACT 
The most common neoplasm found in young to middle-aged men is testicular 
cancer (TCa). This disease not only poses a risk of early death, but can also affect a 
male's fertility and testosterone levels and can diminish one's mental health and/or 
quality of life. One particular line of research that is emerging in the field is a possible 
genetic association of TCa with female reproductive cancers. We employed a 
systematic review to assess the methodological quality of articles that met the 
inclusionary criteria. To be selected for this review, articles had to go through a primary, 
secondary, and tertiary screening procedure using the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) statement guidelines. Four studies 
were selected, and the Newcastle-Ottawa Scale (NOS) was used to measure the quality 
of each nonrandomized, case-control or cohort study. Two articles received perfect 
scores, one case-control study received a near-perfect score of 8 out of 9 stars, and 
only one out of the four included studies received 5 out of 9 stars. Upon organizing and 
analyzing the data, we found a significantly increased risk (20%) of female reproductive 
cancer among women who had a father with TCa. Also, we found that men were 12% 
more likely to develop TCa if they had a sister with female reproductive cancer, and 
16% more likely if their mother had ovarian, endometrial, breast or cervical cancer. The 
goal of this review was to assess the overall strength of association, or lack thereof, 
between TCa and female reproductive cancers. Findings of this review suggest that an 
association exists between these discordant forms of cancer. There were significant 
risks found between mothers and sons, backed by substantial evidence of an X-linked 
inheritance pattern. This information has the potential to improve our knowledge of 
cancer etiology and treatment. 
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Introduction 
Testicular Cancer Overview 
Testicular cancer (TCa) is defined as a malignancy that develops in the tissue of 
one or both testes (National Cancer Institute, 2019). TCa is a relatively rarer cancer 
throughout the world but is the most common neoplasm in men aged 14 to 44 (Cheng et 
al., 2018). The most common type of testicular malignancy is known as testicular germ 
cell tumors (TGCT), caused by a neoplasm derived from germ cells (McGlynn et al., 
2010). 
Over the last 40 years, the incidence of TCa has been increasing at a steady 
rate, primarily among Caucasian males (Park et al., 2018). Currently, TCa accounts for 
roughly 1-1.5% of all cancers in the global male population, and is the most common 
malignancy in young adult men aged 20-40 years old (Boccellino et al., 2017).  
Potential Causal Factors 
Family history is the greatest risk factor for developing TCa, possibly due to 
shared environmental exposure, or an X-linked/autosomal recessive genetic trait (Pyle 
et al., 2016). A few other causal factors of TCa are cryptorchidism, premature birth, low 
birth weight, and twinning (Smith et al., 2018). It is also possible that women with high 
estrogen levels during gestation may be at risk of having sons with TCa (Piltoft et al., 
2017). 
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Female Reproductive Cancer Associations 
Research suggests that TCa may be the result of X-linked inheritance, with a 
genetic susceptibility trait located near an ovarian cancer susceptibility trait on the X-
chromosome (Etter et al., 2018). In a recent study, the researchers at the Roswell Park 
Cancer Institute (2018) discovered an association between TCa and familial ovarian 
cancer by analyzing data from an ovarian cancer registry. By examining the medical 
histories of 34 males with a prior TCa diagnosis, these men were more likely to have a 
mother or sister with familial ovarian cancer, compared to males with other cancer types 
(Etter et al., 2018). Another study suggests that, although rare, there are familial 
associations between female breast cancer and TCa (Zheng et al., 2017). 
Objectives 
To the authors' knowledge, however, no systematic review of literature exists that 
examines the association between TCa and female reproductive cancers. The goal of 
this systematic review, therefore, was to determine the methodological quality of studies 
aiming to demonstrate the possible associations between TCa and female reproductive 
cancers. Future directions and recommendations will be offered to guide future studies 
in this specific line of research.  
Research Question 
Does an association exist between TCa and the various forms of female 
reproductive cancers? 
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Review of Literature 
Testicular Cancer Overview 
Testicular cancer (TCa) is a rare malignancy but most prevalent among men of 
European descent, typically aged 15 to 44 (Znaor et al., 2020). Specifically, 
Scandinavian men have rates of testicular cancer 5 to 10 times greater than those of 
Asian and African ancestry (McGlynn et al., 2010).  
According to one article, “There has been an increase in the incidence of 
testicular cancer in many Western countries over the past 40 years and the global 
incidence of testicular cancer has doubled over the past three decades” (Manecksha & 
Fitzpatrick, 2009). Epidemiology of testicular cancer. BJU international, 104(9b), 1329-
1333. Specifically, between 1973 and 2002, white American men experienced a 52% 
increase in the incidence of TCa (Chia et al., 2010). Additionally, research shows that 
Eastern Europe is predicted to see a 32% increase in TCa cases between 2010 and 
2035 (Znaor et al., 2020). 
Epidemiology and Prevalence 
In 2020, there were an estimated 9,610 new cases of TCa, with 440 estimated 
deaths in the United States alone (American Cancer Society, 2020). In addition, the 
incidence among U.S. men rose by roughly 19% from 1992 (5.7 per 100,000) to 2009 
(6.8 per 100,000) (Nigam et al., 2015). Luckily, medical advancements have improved 
the 5-year survival rate of TCa to 97% from 2005 to 2011 (Siegel et al., 2016). 
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However, the incidence of TGCT in Maori men of New Zealand is much more 
prevalent. In 2002, Maori men had 10.6 cases per 100,000, in contrast to non-Maori 
men who had significantly less cases, with 3.5 per 100,000 (New Zealand Health 
Information Service 2006). 
Etiology and Risk Associations 
Testicular germ cell tumors (TGCT) are believed to develop from intratubular 
germ cell neoplasia (IGCN), commonly known as carcinoma in situ (CIS) (Batool et al., 
2019). Roughly 98% of all TGCTs develop from germ cells, with more than half being 
seminomas (55%), while the remaining are nonseminomas (44%) and spermatocytic 
seminomas (1%) (McGlynn et al., 2010). 
Pre-existing medical conditions seem to pose a risk of TGCT development in 
addition to race/ethnicity (McGlynn et al., 2010). Cryptorchidism, commonly known as 
undescended testicle(s), is the disorder most closely related to the formation of 
testicular cancer (Smith et al., 2018). Patients diagnosed with cryptorchidism are about 
4.3 times more likely to develop TGCT than patients without (Cook et al., 2010). While 
there is no definitive relationship, research shows that there may be genetic 
components that increase the likelihood of developing TCa among brothers and sons of 
affected individuals (Batool et al., 2019). 
Female Reproductive Links 
Family history of TCa is a risk factor for developing TCa (Smith et al., 2018). 
However, it is unknown if female reproductive cancers are a risk factor for testicular 
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cancer in males. Etter and colleagues (2018) state that there is “evidence for several 
susceptibility genes, including 27 identified autosomal loci and a putative X-linked gene 
at Xq27, TGCT1” (p. 184). This indicates a possible familial association between male 
and female genitourinary tract anomalies. 
In the past three decades, research has been conducted with results linking TCa 
to the X-chromosome (Looijenga et al., 1997). This is significant because human males 
normally have one X chromosome and one Y chromosome, obtaining one sex 
chromosome from each parent. Therefore, male offspring will receive their X 
chromosome from the mother, and their Y chromosome from the father. 
Interestingly enough, Eng and colleagues (2018) identified that this X-linked 
testicular cancer susceptibility gene is located in close proximity to an ovarian cancer 
susceptibility gene (Eng et al., 2018). This further proves that these recognized familial 
germ cell neoplasms are driven by this X-linked gene.  
Giambartolomei and colleagues, “found evidence of familial [ovarian germ cell 
tumor] clustering, both site-specific and in combination with TGCT, and noted distinct 
histologic patterns for ovarian germ cell tumors (OGCT) and TGCT, by age.” 
(Giambartolomei et al., 2009, pg. 5). They claim this supports the theory that ovarian 
germ cell tumors may be a rare manifestation of familial gonadal tumor syndrome. 
Another study by Zheng and colleagues (2017) suggests, albeit rare, familial 
associations may be present between female breast cancer and TCa. 
This accumulating evidence implies that associations between TCa and female 
reproductive cancers may exist. Further investigation is needed to discover definitive 




A systematic review was employed to assess the methodological quality of 
qualified articles to assess the strength of association between the manifestation of TCa 
and a family history of female reproductive cancers. Each article was analyzed using 
the Newcastle-Ottawa Scale (NOS) to measure the quality of each study. Sources were 
screened and selected by following the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) statement guidelines (Liberati et al. 2009). 
Data Reference and Search Strategy 
The Medical Subject Headings (MeSH) database was used to index articles and 
develop keywords to search pertinent literature. The Cumulative Index to Nursing and 
Allied Health Literature (CINAHL; 1990 to present), PubMed (1990 to present), 
ProQuest (1990 to present), and Google Scholar (1990 to present) databases were 
used to find literature relevant to this study. Keywords used to search literature included 
variants of testicular cancer, neoplasms, epidemiology, mortality, female reproductive, 
ovarian, gonadal, familial association, genetic predisposition, and inheritance. 
Study Selection 
Inclusion and Exclusion Criteria 
Studies were required to meet the following inclusionary criteria to be evaluated 
in the systematic review and assessed using the NOS. Only peer-reviewed, scholarly 
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articles were included in the screening process. Articles had to be epidemiologically-
focused analytical studies showing associations between testicular cancer and female 
reproductive cancers in order to be accepted. 
Genetically-focused articles that focus solely on the pathophysiological 
processes of TCa were excluded from the systematic review. Furthermore, drug 
patents, medical procedures, case studies, review papers, and interventions were also 
rejected. Non-peer reviewed articles were excluded from the screening procedure. 
Screening Procedure  
The PRISMA flow diagram was used to organize the flow of selection of studies 
while screening peer-reviewed journals. This tool was used to map out the number of 
studies included or excluded in each primary, secondary, and tertiary screening stage. 
The qualifying studies were assessed using the following screening guidelines: 
Primary Screening 
First, titles and abstracts were screened based upon their relevance to the study 
objectives. Any articles showing an association between testicular cancer and other 
cancers were kept for further screening. Non-peer reviewed articles and unpublished 
materials were excluded. 
Secondary Screening 
Then, full articles were screened for relevance. Articles showing a link between 
testicular cancer and the main types of female reproductive cancer were kept for further 
8 
screening. Female reproductive cancers are inclusive of cervical, ovarian, uterine, 
endometrium, vaginal, vulvar, and breast cancer (Mun et al., 2015). 
Tertiary Screening 
Last, articles that showed definitive evidence of an association between TCa and 
female reproductive cancer were kept for the data extraction. These articles were then 
assessed using the NOS. 
Data Extraction and Methodological Quality Assessment 
Overview 
The articles deemed relevant were scored using the NOS, to measure the quality 
of nonrandomized studies, including, but not limited to, case-control and cohort studies. 
Data Extraction and Quality 
The information collected from each study included study design, number of 
human subjects, confounding variables and method of control. Additional information 
consisted of TCa characteristics identified, which female reproductive cancers were 
investigated, and results and data. The results were summarized by utilizing an odds-
ratio and confidence interval. The NOS assessed the methodological quality of cohort 
and case-control studies with nine evaluation items on the adequacy of the 
recruitment/selection process of study participants (4 items), comparability of 






Multiple searches were conducted using the Cumulative Index to Nursing and 
Allied Health Literature (CINAHL; 1990 to present), PubMed (1990 to present), 
ProQuest (1990 to present), and Google Scholar (1990 to present) databases using the 
keywords testicular cancer, neoplasms, epidemiology, mortality, female reproductive, 
ovarian, gonadal, familial association, genetic predisposition, and inheritance.  
Search Results 
These searches returned approximately 3,780 results (Figure 1). Once the 
duplicates were removed, there were 3,402 records remaining. Any patents, clinical 
trials, or other studies that did not have a cohort or case-control study design were 
rejected (n = 2,374). Next, titles and abstracts were screened based upon their 
relevance to the thesis, while non-peer reviewed articles and unpublished materials 
were excluded (n = 786). Any articles showing an association between TCa and other 
cancers were kept for secondary screening. Of the remaining 242 records, full articles 
were screened for relevance. Articles that displayed an association between TCa and 
the main types of female reproductive cancer (cervical, ovarian, uterine, vaginal, vulvar, 
and breast cancer) were kept for tertiary screening (n = 12). Last, articles that showed 
definitive evidence of an association between TCa and female reproductive cancer were 
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kept for the systematic review (n = 4). These articles were then assessed using the 
NOS quality assessment tool. 
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irrelevant studies 
excluded) 
 Studies included in 
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(n = 12) 
Studies included in 
quantitative synthesis 
(systematic review) 
(n = 4) 
Figure 1. PRISMA Flow Diagram. 
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Included Studies 
 There were four studies that met the eligibility requirements for the systematic 
review (Table 1). This was inclusive of two cohort studies (Zheng et al., 2017; Hemminki 
et al., 2005), and two case-control studies (Etter et al., 2018; Nordsborg et al., 2011). 
Each study was evaluated using the NOS scale. Three out of the four studies (Zheng et 
al., 2017; Hemminki et al., 2005; Nordsborg et al., 2011) achieved a good quality score. 
There was only study (Etter et al., 2018) that received an acceptable quality score of 5 
out of 9 stars. 
 The measures of association were depicted in an estimated hereditary risk table 
(Table 2). This table illustrates the estimated risk of a first-degree relative with either 
TCa or female reproductive cancer. The data is organized as two groups of hereditary 
directionalities (male to female; female to male), separated into five subgroups (father to 
daughter; brother to sister; son to mother; sister to brother; mother to son). For 
example, the risk ratio of female breast cancer was 1.14 (95% CI 1.00-1.30) for women 
who had a father with TCa. The estimated risk of each hereditary directionality was then 
calculated by meta-analysis using random effects models averaging the ratios 
associated with their corresponding subgroup. 
The average estimated risk (shown in Table 2) of female reproductive cancer 
was found to be 20% higher in women who had a father with TCa. Women who had a 
brother with TCa were only 1% more likely to develop female reproductive cancer. 
There was no significant association found between women with female reproductive 
cancer who had sons with TCa. Men who had a sister with female reproductive cancer 
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were 12% more likely to develop TCa, and 16% more likely if they had a mother with 
ovary, endometrium, breast or cervix cancer.  
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Table 1. Study summaries of 4 articles included in systematic review. 
Author Name(s) Etter Nordsborg Zheng Hemminki 
Date 2018 2011 2017 2005 




Region of Study USA Denmark Sweden Sweden 
Number of Participants 
2,636 families with multiple 
cases of ovarian cancer 
9,891 
76,060 female offspring with 
BC (12266 families) 
175,635 off springs 
Data source 
Familial Ovarian Cancer 
Registry 
Danish Cancer Registry for 
cases and Danish Civil 






Age (years)  Median 35 (0-96) 0-70  0-70 
Cases 34 men with testicular cancer 3,297 with testicular cancer   
Controls 
2,894 men with non-testicular 
cancer 
6,594 matched controls   
Exposure 
First-degree relatives (FDR) 
with ovarian cancer 
First-degree relatives with 
other cancers 
  
Outcome   
Familial cancer risk in 
offspring/FDR in two ways 
Familial cancer risk in 
offspring/FDR in two ways 
Follow-up Period    1958-2002 
Incidence    
4,586 TC in sons and 4315 in 
fathers 
Confounder Included in 
Study 
None - univariate logistic 
regression 
Number of relatives 
Age group, sex, calendar 
period, residential area, and 
SES 
Age, sex, tumor type, period, 
ses, residential area 
Quality Score 5 8 9 9 
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Table 2. Measures of association of the estimated hereditary risk. 
*FDR = first-degree relative
 
Male to female Female to male 
Hereditary 
Directionality 
Father’s with TCa  
daughter’s with female 
reproductive cancer 
Brother’s with TCa  
sister’s with female 
reproductive cancer 
Sons with TCa  
mother’s with female 
reproductive cancer 
Sister’s with female 
reproductive cancer  
brother with TCa 
Mother’s with female 
reproductive cancer  
son’s with TCa 
Risk Ratio 
RR for breast cancer = 
1.06 (0.86-1.31) when 
any FDR* had TCa 
RR for breast cancer = 
1.14 (1.00-1.30) when 
brother had TCa 
RR for breast cancer = 
1.06 (0.86-1.31) when 
any FDR* had TCa 
RR for TCa = 1.66 (0.87-
3.15) when sister had 
ovary cancer 
RR for TCa = 3.32 (1.46-
7.55) when mother had 
ovary cancer 
RR for female genital 
organ cancer = 0.89 
(0.68-1.16) when any 
FDR* had TCa 
RR for breast cancer = 
0.90 (0.66-1.22) when 
brother had TCa 
RR for female genital 
organ cancer = 0.89 
(0.68-1.16) when any 
FDR* had TCa 
RR for TCa = 1.14 (1.06-
1.23) when sister had 
breast cancer 
RR for TCa = 1.14 (1.06-
1.23) when mother had 
breast cancer 
RR for breast cancer = 
1.14 (1.00-1.30) when 
father had TCa 
RR for cervix cancer = 
1.68 (0.87-3.24) when 
brother had TCa 
 
RR for TCa = 0.98 (0.63-
1.52) when sister had 
breast cancer 
RR for TCa = 1.17 (0.98-
1.39) when mother had 
breast cancer 
RR for breast cancer = 
1.28 (0.85-1.92) when 
father had TCa 
RR for endometrium 
cancer = 1.09 (0.50-
2.38) when brother had 
TCa 
 
RR for TCa = 0.80 (0.31-
2.07) when sister had 
cervix cancer 
RR for TCa = 0.74 (0.44-
1.25) when mother had 
cervix cancer 
RR for cervix cancer = 
0.69 (0.19-2.54) when 
father had TCa 
RR for ovary cancer = 
0.97 (0.44-2.14) when 
brother had TCa 
 
RR for TCa = 1.34 (0.45-
3.98) when sister had 
endometrium cancer 
RR for TCa = 1.05 (0.70-
1.57) when mother had 
endometrium cancer 
RR for endometrium 
cancer = 1.52 (0.51-
4.49) when father had 
TCa 
  
RR for TCa = 1.11 (0.43-
2.88) when sister had 
ovary cancer 
RR for TCa = 1.14 (0.76-
1.71) when mother had 
ovary cancer 
RR for ovary cancer = 
0.75 (0.20-2.75) when 
father had TCa 








 The Newcastle-Ottawa assessment scale is well-known for determining the 
quality scores of articles and assessing the risk of bias. A ‘star-system’ is utilized to 
measure the quality of cohort and case-control studies. This systematic review preferred 
the NOS tool, in order to measure the quality of articles that showed an association 
between TCa and female reproductive cancers. Each article that passed the tertiary 
screening process was analyzed using the NOS to measure the quality of 
nonrandomized study. This quality assessment tool utilizes a ‘star system’ to evaluate 
the study group selection, comparability, and ascertainment of the exposure or outcome 
of interest. 
Systematic Review Findings 
 A total of four studies were eligible for use in the systematic review (Zheng et al., 
2017; Hemminki et al., 2005, Etter et al., 2018; Nordsborg et al., 2011). Church and 
colleagues deliberated in order to agree upon a score for each selected study. Two 
articles (Zheng et al., 2017; Hemminki et al., 2005) received perfect scores (shown in 
Table 3) according to the NOS requirements. In other words, these two studies 
contained quality selection of groups, comparability, and ascertainment of outcomes. 
This signifies that both of these studies were of good quality. One case-control study 
(Nordsborg et al., 2011) received a near-perfect score of 8 out of 9 stars, due to the lack 
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of non-response rate provided (Table 4). However, this is still considered to be a study 
of good quality. Only one out of the four included studies (Etter et al., 2018) was found 
to be of acceptable quality. This conclusion was met due to a lack of comparability, 













Table 4. Methodological quality assessment of case-control studies included in the systematic review. 
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Key Findings 
 Upon calculating the average estimated risk for each subgroup (shown in Table 
2), we can infer that males are 16% more likely to develop TCa when their mother has 
female reproductive cancer (inclusive of ovarian, breast, cervix and endometrial 
cancer). This may be due to a probable X-linked trait passed from mother to son. As 
previously stated, one study identified an X-linked TCa susceptibility gene in close 
proximity to an ovarian cancer susceptibility gene (Eng et al., 2018). This further proves 
that an association exists between TCa and female reproductive cancer. 
 By compiling the available data into forest plots (Figures 2 through 5), the risk of 
discordant cancer inheritance was concluded. The hereditary risk of developing TCa 
was found to be 14% higher among men who had a mother or sister with female 
reproductive cancer (shown in Figure 2 and Figure 4). 
 Additionally, the limited number of eligible studies may not fully reflect each 
individual risk. For example, the risk of female reproductive cancer was merely 8% 
higher in women with a father or brother that had TCa (shown in Figure 3 and Figure 5). 
However, because evidence is sparse, this may actually indicate a clinically significant 
risk factor. 
 There are other variables that must be considered. Mother’s and son’s may be 









Strengths and Limitations 
 This systematic review was not without its own limitations. It proved challenging 
to find articles that met the eligibility requirements. To the authors knowledge, there is 
no other systematic review of literature that examines the association between TCa and 
female reproductive cancers. This is still a novel and developing field of study, so there 
is a very limited amount of epidemiological analytical studies focused on the 
associations between these discordant cancers. More studies must be conducted to 
achieve more accurate results. 
Conclusion 
The purpose of this study was to determine the methodological quality of 
nonrandomized studies showing any possible associations between TCa and female 
reproductive cancer. Findings of this review suggest that an association exists between 
these discordant cancers. There were significant risks found between mothers and 
sons, backed by substantial evidence of an X-linked inheritance pattern. We hope to 
bring attention to this field of study so that more definitive evidence may be derived. 
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